Live Oak Health Sciences Fund LOGSX

Morningstar Medalist Rating
  • NAV / 1-Day Return $27.17  /  −1.20 %
  • Fund Size $66.4M
  • Adjusted Expense Ratio 1.040%
  • Net Expense Ratio 1.040%
  • Fee Level: Distribution Above Average
  • Share Class Type Institutional
  • Morningstar Category Health
  • Equity Style Box (Funds) Mid Value
  • Minimum Initial Investment $2,000
  • Investment Status Open
  • TTM Yield 0.09%
  • Turnover Ratio 24%

Morningstar’s Analysis LOGSX

Will LOGSX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Live Oak Health Sciences holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LOGSX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 45.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Prime 3.53 10/1/26

6.20 4M
—

Cardinal Health Inc

5.22 3M
Healthcare

Exelixis Inc

5.03 3M
Healthcare

United Therapeutics Corp

4.93 3M
Healthcare

Amgen Inc

4.90 3M
Healthcare

Jazz Pharmaceuticals PLC

4.87 3M
Healthcare

Lantheus Holdings Inc

4.30 3M
Healthcare

McKesson Corp

4.17 3M
Healthcare

Regeneron Pharmaceuticals Inc

4.06 2M
Healthcare

Cencora Inc

3.96 2M
Healthcare

Sponsor Center